Tymazoline: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
m (Protected "Tymazoline": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{Drugbox
{{Drugbox
| IUPAC_name       = 2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole
| Verifiedfields = changed
| image             = Tymazoline.png
| Watchedfields = changed
| CAS_number        =  
| verifiedrevid = 470619043
| ATC_prefix        = R01
| IUPAC_name = 2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole
| ATC_suffix        = AA13
| image = Tymazoline.png
| PubChem          = 34154
 
| DrugBank          =  
<!--Clinical data-->
| chemical_formula  =  
| tradename = Thymazen
| C=14|H=20|N=2|O=1
| Drugs.com = {{drugs.com|international|tymazoline}}
| molecular_weight  = 232.321 g/mol
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| bioavailability   =  
| pregnancy_US = <!-- A / B            / C / D / X -->
| protein_bound     =  
| pregnancy_category =  
| metabolism       =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Nasal
 
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| elimination_half-life =  
| excretion         =  
| excretion =  
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
 
| pregnancy_US      = <!-- A / B            / C / D / X -->
<!--Identifiers-->
| pregnancy_category=
| CAS_number_Ref = {{cascite|changed|??}}
| legal_AU          = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| CAS_number = 24243-97-8
| legal_CA          =  <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| ATC_prefix = R01
| legal_UK          =  <!-- GSL        / P      / POM / CD / Class A, B, C -->
| ATC_suffix = AA13
| legal_US          =  <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| PubChem = 34154
| legal_status      =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| routes_of_administration =  
| DrugBank = DB08803
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 31478
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U993RH5585
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D07373
 
<!--Chemical data-->
| chemical_formula =
| C=14 | H=20 | N=2 | O=1
| molecular_weight = 232.321 g/mol
| smiles = Cc1ccc(c2c1cccc2OCC3=NCCN3)C(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H20N2O/c1-10(2)12-5-4-11(3)8-13(12)17-9-14-15-6-7-16-14/h4-5,8,10H,6-7,9H2,1-3H3,(H,15,16)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QRORCRWSRPKEHR-UHFFFAOYSA-N
}}
}}
                    __NOTOC__
{{SI}}
{{CMG}}
{{CMG}}
==Overview==


 
'''Tymazoline''' (trade name '''Thymazen''' in Poland) is a nasal [[decongestant]] that can be used to treat [[rhinitis]]. It acts as an [[antihistaminic]] and [[sympathomimetic]], reducing swelling, inflammation and mucosal secretions.<ref>[[Drugs.com]]: [http://www.drugs.com/international/tymazoline.html Tymazoline]</ref><ref>[[DrugBank]]: [http://www.drugbank.ca/drugs/DB08803 Tymazoline]</ref>
 
==References==
'''Tymazoline''' is a nasal preparation.
{{reflist|2}}


{{Nasal preparations}}
{{Nasal preparations}}


[[Category:Imidazolines]]
[[Category:Imidazolines]]
 
[[Category:Phenol ethers]]
{{WH}}
[[Category:Drug]]
{{WS}}

Latest revision as of 17:22, 20 August 2015

Tymazoline
Clinical data
Trade namesThymazen
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Nasal
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H20N2O
Molar mass232.321 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)


WikiDoc Resources for Tymazoline

Articles

Most recent articles on Tymazoline

Most cited articles on Tymazoline

Review articles on Tymazoline

Articles on Tymazoline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tymazoline

Images of Tymazoline

Photos of Tymazoline

Podcasts & MP3s on Tymazoline

Videos on Tymazoline

Evidence Based Medicine

Cochrane Collaboration on Tymazoline

Bandolier on Tymazoline

TRIP on Tymazoline

Clinical Trials

Ongoing Trials on Tymazoline at Clinical Trials.gov

Trial results on Tymazoline

Clinical Trials on Tymazoline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tymazoline

NICE Guidance on Tymazoline

NHS PRODIGY Guidance

FDA on Tymazoline

CDC on Tymazoline

Books

Books on Tymazoline

News

Tymazoline in the news

Be alerted to news on Tymazoline

News trends on Tymazoline

Commentary

Blogs on Tymazoline

Definitions

Definitions of Tymazoline

Patient Resources / Community

Patient resources on Tymazoline

Discussion groups on Tymazoline

Patient Handouts on Tymazoline

Directions to Hospitals Treating Tymazoline

Risk calculators and risk factors for Tymazoline

Healthcare Provider Resources

Symptoms of Tymazoline

Causes & Risk Factors for Tymazoline

Diagnostic studies for Tymazoline

Treatment of Tymazoline

Continuing Medical Education (CME)

CME Programs on Tymazoline

International

Tymazoline en Espanol

Tymazoline en Francais

Business

Tymazoline in the Marketplace

Patents on Tymazoline

Experimental / Informatics

List of terms related to Tymazoline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tymazoline (trade name Thymazen in Poland) is a nasal decongestant that can be used to treat rhinitis. It acts as an antihistaminic and sympathomimetic, reducing swelling, inflammation and mucosal secretions.[1][2]

References